墨尔本移动卒中单元与再灌注治疗:取栓的临床影响大于溶栓
该研究比较了墨尔本移动卒中单元(MSU)首年运行中接受再灌注治疗的患者与标准急救转诊对照者的治疗时间指标,发现MSU显著缩短了溶栓和取栓的治疗时间,且取栓带来的估计残疾调整生命年避免数更大。
要点
- MSU使溶栓从派遣至治疗时间节省42.5分钟(95%CI 36.0-49.0)。
- MSU使取栓从派遣至治疗时间节省51分钟(95%CI 30.1-71.9)。
- 取栓的估计残疾调整生命年避免数(24.6)高于溶栓(20.9)。
核心结论
- 墨尔本MSU大幅缩短了再灌注治疗时间,且取栓带来的估计残疾避免效益更大。
研究设计与样本
- 研究比较了MSU首年运行中接受再灌注治疗的患者与MSU运行时段内经标准救护车到达墨尔本都市卒中单元的对照患者。
- 采用分位数回归分析从首次救护车派遣至治疗的中位时间差,并将时间节省转换为残疾调整生命年避免数。
主要发现
- MSU溶栓患者100例(平均年龄73.8岁,62%男性),从派遣至入院中位时间节省26分钟(P<0.001),入院至溶栓节省15分钟(P<0.001)。
- MSU取栓患者41例(平均年龄76岁,61%男性),从派遣至治疗中位时间节省51分钟(95%CI 30.1-71.9,P<0.001),入院至动脉穿刺节省17分钟(95%CI 7.6-26.4,P=0.001)。
- 估计通过早期再灌注治疗避免的中位残疾调整生命年:溶栓为20.9,取栓为24.6。
临床怎么用
- MSU应加强院前通知并直接分诊至取栓中心,以促进到院后工作流程顺畅。
- MSU的获益不仅限于溶栓,对取栓的时间节省和残疾避免可能更大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Mobile stroke units (MSUs) are increasingly used worldwide to provide prehospital triage and treatment. The benefits of MSUs in giving earlier thrombolysis have been well established, but the impacts of MSUs on endovascular thrombectomy (EVT) and effect on disability avoidance are largely unknown. We aimed to determine the clinical impact and disability reduction for reperfusion therapies in the first operational year of the Melbourne MSU. Methods- Treatment time metrics for MSU patients receiving reperfusion therapy were compared with control patients presenting to metropolitan Melbourne stroke units via standard ambulance within MSU operating hours. The primary outcome was median time difference in first ambulance dispatch to treatment modeled using quantile regression analysis. Time savings were subsequently converted to disability-adjusted life years avoided using published estimates. Results- In the first 365-day operation of the Melbourne MSU, prehospital thrombolysis was administered to 100 patients (mean age, 73.8 years; 62% men). The median time savings per MSU patient, compared with the control cohort, was 26 minutes (P<0.001) for dispatch to hospital arrival and 15 minutes (P<0.001) for hospital arrival to thrombolysis. The calculated overall time saving from dispatch to thrombolysis was 42.5 minutes (95% CI, 36.0-49.0). In the same period, 41 MSU patients received EVT (mean age, 76 years; 61% men) with median dispatch-to-treatment time saving of 51 minutes ([95% CI, 30.1-71.9], P<0.001). This included a median time saving of 17 minutes ([95% CI, 7.6-26.4], P=0.001) for EVT hospital arrival to arterial puncture for MSU patients. Estimated median disability-adjusted life years saved through earlier provision of reperfusion therapies were 20.9 for thrombolysis and 24.6 for EVT. Conclusions- The Melbourne MSU substantially reduced time to reperfusion therapies, with the greatest estimated disability avoidance driven by the more powerful impact of earlier EVT. These findings highlight the benefits of prehospital notification and direct triage to EVT centers with facilitated workflow on arrival by the MSU.
引用
- Zhao H, Coote S, Easton D, et al. Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than Thrombolysis. Stroke. 2020. PMID: 32078483. doi:10.1161/STROKEAHA.119.027843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。